VasQ External Support for Arteriovenous Fistula
NCT03242343
Aneurysm, Arterio-venous Fistula
Birmingham, Alabama, United States
View Trial DetailsNCT Number: NCT00437944
The rational of the study is to try to predict which of the patients who suffer from Fabry disease will have End Stage Renal Disease. We hope to find correlation between certain modifier genes, previously related to renal disease, to renal disease in Fabry.
Looking for future studies?
Notify MeAll sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Fabry disease -
Exclusion criteria
none
-
Shaare Zedek Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03242343
Aneurysm, Arterio-venous Fistula
Birmingham, Alabama, United States
View Trial DetailsNCT05700903
Androgen Deprivation Therapy, Autonomic Dysfunction
Aurora, Colorado, United States
View Trial DetailsNCT06614712
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Seville, Spain
View Trial DetailsNCT04380610
Anemia, Anemia, Hemolytic
Birmingham, Alabama, United States
View Trial Details